NCRIS Turbo-Charges New mRNA Drugs
Therapeutics that use mRNA are a growing area of development and work by introducing the ‘’message” to make a therapeutic protein into the patient’s body, instead of the protein itself. This approach can revolutionise combatting many kinds of cancers, and for treating genetic and infectious diseases. Conventional strategies deliver mRNA drugs to tissues inside lipid […]
BASE Facility Shares Open Protocol to Democratise mRNA Therapeutics
BASE Facility, supported by Therapeutic Innovation Australia (TIA) through the National Collaborative Research Infrastructure Strategy (NCRIS), has published a new open-access protocol that simplifies and streamlines the production of high-quality mRNA for research and preclinical applications. Published in Nature Protocols, this end-to-end guide walks researchers through the complete mRNA production workflow—from sequence design and DNA template […]
Building Australia’s RNA Biomanufacturing Workforce
Building Australia’s RNA Biomanufacturing Workforce: TIA Facilities Deliver Hands-On Training Several of Therapeutic Innovation Australia’s facilities are making major strides in workforce development through hands-on training programs that foster the next generation of RNA biomanufacturing experts. Recently, the UNSW RNA Institute launched its inaugural training program, offering four courses in RNA therapeutics manufacturing and quality […]
BASE mRNA Facility
mRNA vaccines and therapies provide a new strategy to treat disease. The BASE facility makes mRNA for scientific research. This facility has experience making hundreds of mRNAs vaccines and therapies. BASE offers end-to-end services, including the design, manufacture and LNP formulation of mRNA, and also provide off-the-shelf mRNAs. Read more about BASE here
